Interestingly, in a case-control study, serum BDNF and NGF levels were low in patients with early and moderate glaucoma, indicating that the NTFs have a potential to serve as diagnostic biomarkers for glaucoma (Oddone et al., 2017). This evidence concerns the gene BDNF and glaucoma.